Oruka Therapeutics, Inc.
NASDAQ:ORKABiotechnology
Healthcare
$95.74 +0.65%
+$0.46 today
- Market cap
- $6.49B
- Beta
- -0.30
- P/E (TTM)
- -33.9
- EPS (TTM)
- -$2.11
52W Low $10.77High $91.00
Volume 0.52M
Average 1.55M
Balance Sheet
Inspect the capital base behind the business.
Assets
$488.62M
FY 2025 · Annual
+23.4% YoYLiabilities
$16.69M
FY 2025 · Annual
+20.9% YoYEquity
$471.93M
FY 2025 · Annual
+23.5% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 53.36M | 42.45M | 37.43M | 61.58M | 46.94M |
| Short-term Investments | 0 | 0 | 0 | 314.07M | 290.11M |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.06M | 254K | 161K | 1.22M | 6.81M |
| Total Current Assets | 54.42M | 42.7M | 37.59M | 376.87M | 343.86M |
| Property, Plant & Equipment (Net) | 485K | 368K | 257K | 1.04M | 2.12M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 18.07M | 142.54M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 18K | 18K | 12K | 43K | 103K |
| Total Non-current Assets | 503K | 386K | 269K | 19.15M | 144.76M |
| Total Assets | 54.92M | 43.09M | 37.86M | 396.02M | 488.62M |
| Account Payables | 1.12M | 334K | 0 | 3.46M | 4.16M |
| Short-term Debt | 100K | 103K | 76K | 213K | 619K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.36M | 522K | 461K | 7.33M | 5.33M |
| Total Current Liabilities | 3.5M | 1.13M | 637K | 13.04M | 15.37M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 383K | 280K | 204K | 755K | 1.31M |
| Total Liabilities | 3.88M | 1.41M | 841K | 13.8M | 16.69M |
| Common Stock | 14K | 14K | 14K | 37K | 49K |
| Retained Earnings | (173.48M) | (183.4M) | (188.74M) | (83.72M) | (189.16M) |
| Accumulated OCI | 0 | 0 | 0 | (41K) | 546K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 51.04M | 41.67M | 37.02M | 382.22M | 471.93M |
| Total Debt | 483K | 383K | 280K | 968K | 1.93M |
| Net Debt | (52.88M) | (42.06M) | (37.15M) | (60.61M) | (45M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $191.5M |
| Short-term Investments | $728.8M |
| Other Current | $21.2M |
| Total Current Assets | $941.5M |
| PP&E (Net) | $3.1M |
| Long-term Investments | $286.3M |
| Other Non-current | $128.0K |
| Total Non-current Assets | $289.5M |
| Total Assets | $1.2B |
Analysis
Selected assets total $1.2B for Latest. The largest visible component is Short-term Investments at $728.8M, about 59.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 2, 2026 | |
| 8-K | Current report | Oct 26, 2026 |
How much cash does ORKA have?
Oruka Therapeutics, Inc. (ORKA) reported $46.94M in cash and equivalents in fiscal 2025.
How much debt does ORKA carry?
Oruka Therapeutics, Inc. (ORKA) reported $1.93M of total debt, with net debt of -$45.00M.
Continue the stock analysis
Jump to another research area for this company.